CD8A and cancer: These findings showed that high IS® is associated with improvement in outcome, as demonstrated previously for colon [36,37] and rectum [38] cancers, reinforcing the importance of a high ISCR, as well as CD3+ IM, CD8+ IM CD3+ CT, and CD8+ CT adding relevance to the spatial distribution of these cells.